Progression and prognosis in multiple system atrophy: An analysis of 230 Japanese patients

Brain

Volumn 125, Issue 5, 2002, Pages 1070-1083

  Watanabe, Hirohisa ^a   Saito, Yufuko ^c   Terao, Shinichi ^e   Ando, Tetsuo ^d   Kachi, Teruhiko ^f   Mukai, Eiichiro ^b   Aiba, Ikuko ^c   Abe, Yuji ^a   Tamakoshi, Akiko ^a   Doyu, Manabu ^a   Hirayama, Masaaki ^a   Sobue, Gen ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

^c Meito ku   (Japan)

^d NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^e AICHI MEDICAL UNIVERSITY   (Japan)

^f CHUBU NATIONAL HOSPITAL   (Japan)

Author keywords

Activities of daily living; Early symptoms; Multiple system atrophy; Progression; Survival

Indexed keywords

ADULT; AGED; ARTICLE; AUTONOMIC DYSFUNCTION; CEREBELLUM ATROPHY; CEREBELLUM INJURY; CEREBELLUM VERMIS; DAILY LIFE ACTIVITY; DISEASE COURSE; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIVOPONTOCEREBELLAR ATROPHY; ONSET AGE; PARKINSONISM; POSTERIOR FOSSA; PRIORITY JOURNAL; PROGNOSIS; PUTAMEN; RISK FACTOR; SHY DRAGER SYNDROME; STRIATONIGRAL DEGENERATION; SURVIVAL; WALKING AID; WHEELCHAIR;

EID: 0036241996     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awf117     Document Type: Article

References (59)

1. CAG repeat number correlates with the rate of brainstem and cerebellar atrophy in Machado-Joseph disease
2. Dégénérescences nigro-striées et cérébello-nigro-striées (Unicité clinique et variabilité pathologique des dégénérescences préséniles à forme de rigidité extrapyramidale)
3. Striato-nigral degeneration
4. Degenerative disease of the nervous system associated with autonomic failure
5. Survival of patients with pathologically proven multiple system atrophy: A meta-analysis
6. The striatonigral degenerations: Putaminal pigments and nosology
7. Oligodendroglial inclusions, a marker of multisystemic atrophies
8. L'atrophie olivo-ponto-cérébelleuse
9. Widespread alterations of alpha-synuclein in multiple system atrophy
10. The relationship of multiple system atrophy to sporadic olivopontocerebellar atrophy and other forms of idiopathic late-onset cerebellar atrophy
11. Consensus statement on the diagnosis of multiple system atrophy
12. Evolution of sporadic olivopontocerebellar atrophy into multiple system atrophy
13. Striatonigral degeneration associated with olivopontocerebellar atrophy. Anatomo-clinical study of 3 cases
14. Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy
15. Cerebral atrophy in multiple system atrophy by MRI
16. Autonomic failure with orthostatic hypotension due to intermediolateral column degeneration. A report of two cases with autopsies
17. Spinocerebellar degeneration in Japan - The features from an epidemiological study
18. Idiopathic cerebellar ataxia of late onset: Natural history and MRI morphology
19. The natural history of degenerative ataxia: A retrospective study in 466 patients
20. Clinical and magnetic resonance imaging study of extrapyramidal symptoms in multiple system atrophy
21. Multiple system atrophy with remarkable frontal lobe atrophy
22. The combination of hypointense and hyperintense signal changes on T2-weighted magnetic resonance imaging sequences. A specific marker of multiple system atrophy?
23. A histometrical and comparative study on Purkinje cell loss and olivary nucleus cell loss in multiple system atrophy
24. Hemi-parkinsonism in multiple system atrophy: A PET and MRI study
25. Neuronal cell loss of the striatonigral system in multiple system atrophy
26. Midsaggital MR measurements of the corpus callosum in healthy subjects and diseased patients: A prospective survey
27. What is the accuracy of the clinical diagnosis of multiple system atrophy?
28. Disorders of movement and system degenerations
29. Investigation of autonomic disorders
30. Multiple system atrophy/progressive supranuclear palsy: α-synuclein, synphilin, tau, and APOE
31. Oligodendroglial microtubular tangles in olivopontocerebellar atrophy
32. The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology
33. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome)
34. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
35. Multiple system atrophy. Clinical aspects, pathophysiology, and treatment
36. Hereditary ataxias and paraplegias in Cantabria, Spain
37. A clinico-pathological study on multiple system atrophy, with special reference to its striato-nigral lesions and motor neuron involvements
38. Survival of patients with multiple system atrophy
39. Olivopontocerebellar atrophy: MR diagnosis and relationship to multiple system atrophy
40. Clinical usefulness of magnetic resonance imaging in multisystem atrophy
41. Differentiation of atypical parkinsonian syndromes with routine MRI
42. Multiple system atrophy: Natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT
43. Signal changes on MRI and increases in reactive microgliosis, astrogliosis, and iron in the putamen of two patients with multiple system atrophy
44. A neurological syndrome associated with orthostatic hypotension: A clinical-pathologic study
45. Shy-Drager syndrome: Neuronal loss depends on size, function, and topography in ventral spinal outflow
46. Size-dependent myelinated fiber loss in the corticospinal tract in Shy-Drager syndrome and amyotrophic lateral sclerosis
47. Somatic motor efferents in multiple system atrophy with autonomic failure: A clinico-pathological study
48. Multiple system atrophy with autonomic failure
49. Magnetic resonance imaging in Parkinson's disease and parkinsonian syndrome
50. Shy-Drager syndrome. Its correlation with olivo-ponto-cerebellar atrophy
51. Disease-specific patterns of neuronal loss in the spinal ventral horn in amyotrophic lateral sclerosis, multiple system atrophy and X-linked recessive bulbospinal neuronopathy, with special reference to the loss of small neurons in the intermediate zone
52. Survival in multiple system atrophy: A study of prognostic factors in 59 cases
53. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein
54. T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: Relation to iron content
55. The cerebral peduncle lesion in multiple system atrophy
56. A study of parkinsonism in multiple system atrophy: Clinical and MRI correlation
57. Clinical features and natural history of multiple system atrophy: An analysis of 100 cases
58. Clinicopathological study of 35 cases of multiple system atrophy
59. Multiple system atrophy: A review of 203 pathologically proven cases